4
Views
11
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Use of Transgenic Mice Reveals Cell-Specific Transformation by a Simian Virus 40 T-Antigen Amino-Terminal Mutant

, , , &
Pages 3255-3265 | Received 20 Nov 1992, Accepted 27 Feb 1993, Published online: 01 Apr 2023

REFERENCES

  • Adams, J. M., and S. Cory. 1991. Transgenic models of tumor development. Science 254:1161–1167.
  • Adams, J. M., and S. Cory. 1991. Transgenic models for haemopoietic malignancies. Biochim. Biophys. Acta 1072:9–31.
  • Chen, J., K. Neilson, and T. Van Dyke. 1989. Lymphotropic papovavirus early region is specifically regulated in transgenic mice and efficiently induces neoplasia. J. Virol. 63:2204–2214.
  • Chen, J., G. J. Tobin, J. M. Pipas, and T. Van Dyke. 1992. T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus. Oncogene 7:1167–1175.
  • Chen, J., and T. Van Dyke. 1991. Uniform cell-autonomous tumorigenesis of the choroid plexus by papovavirus large T antigens. Mol. Cell Biol. 11:5968–5976.
  • Clark, R., K. Peden, J. M. Pipas, D. Nathans, and R. Tjian. 1983. Biochemical activities of T-antigen proteins encoded by simian virus 40 A gene deletion mutants. Mol. Cell Biol. 3:220–228.
  • Coffmann, R. L., and I. L. Weissman. 1981. A monoclonal antibody that recognizes B cells and B cell precursors in mice. J. Exp. Med. 153:269–279.
  • Colby, W. W., and T. Shenk. 1982. Fragments of the simian virus 40 transforming gene facilitate transformation of rat embryo cells. Proc. Natl. Acad. Sci. USA 79:5189–5193.
  • DeCaprio, J. A., J. W. Ludlow, J. Figge, J.-Y. Shew, C.-H. Huang, W.-H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275–283.
  • Dobbelstein, M., A. K. Arthur, S. Dehde, K. van Zee, A. Dickmanns, and E. Fanning. 1992. Intracistronic complementation reveals a new function of SV40 T antigen that co-operates with Rb and p53 binding to stimulate DNA synthesis in quiescent cells. Oncogene 7:837–847.
  • Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. MontgomeryJr., J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (London) 356:215–221.
  • Dyson, N., K. Buchkovich, P. Whyte, and E. Harlow. 1989. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58:249–255.
  • Eckner, R., and D. Livingston. 1992. Unpublished data.
  • Egan, C., T. N. Jelsma, J. A. Howe, S. T. Bayley, B. Ferguson, and P. E. Branton. 1988. Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. Mol. Cell. Biol. 8:3955–3959.
  • Ewen, M. E., J. W. Ludlow, E. Marsilio, J. A. DeCaprio, R. C. Millikan, S. H. Cheng, E. Paucha, and D. M. Livingston. 1989. An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110RB and a second cellular protein pl20. Cell 58:257–267.
  • Ewen, M. E., Y. Xing, J. B. Lawrence, and D. M. Livingston. 1991. Molecular cloning, chromosomal mapping, and expression of cDNA for pl07, a retinoblastoma gene product-related protein. Cell 66:1155–1164.
  • Fanning, E. 1992. Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. J. Virol. 66:1289–1293.
  • Fanning, E. 1992. Structure and function of simian virus 40 large tumor antigen. Annu. Rev. Biochem. 61:55–85.
  • Garvin, A. M., K. M. Abraham, K. A. Forbush, A. G. Farr, B. L. Davison, and R. M. Perlmutter. 1990. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int. Immunol. 2:173–180.
  • Green, M. 1989. When the products of oncogenes and antioncogenes meet. Cell 56:1–3.
  • Gurney, E. G., R. O. Harrison, and J. Fenno. 1980. Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct subclasses of large T antigen and for similarities among nonviral antigens. J. Virol. 34:752–763.
  • Hanahan, D. 1989. Transgenic mice as probes into complex systems. Science 246:1265–1275.
  • Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:861–869.
  • Ikuta, K., N. Uchida, J. Friedman, and I. L. Weissman. 1992. Lymphocyte development from stem cells. Annu. Rev. Immu-nol. 10:759–783.
  • Jacks, T. Personal communication.
  • Korsmeyer, S. J. 1992. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879–886.
  • Levine, A. J. 1990. The p53 protein and its interactions with the oncogenic products of the small DNA tumor viruses. Virology 177:419–426.
  • Levine, A. J., and J. Momand. 1990. Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products. Biochim. Biophys. Acta 1032:119–136.
  • Livingston, D. M., and M. K. Bradley. 1987. The simian virus 40 large T antigen: a lot packed into a little. Mol. Biol. Med. 4:63–80.
  • Lowe, S., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (London), in press.
  • Ludlow, J. W., J. Shon, J. M. Pipas, D. M. Livingston, and J. A. DeCaprio. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387–396.
  • Manfredi, J. J., and C. Prives. 1990. Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen. J. Virol. 64:5250–5259.
  • Mares, V., and Z. Lodin. 1974. An autoradiographic study of DNA synthesis in adolescent and adult mouse forebrain. Brain Res. 76:557–561.
  • Marshall, C. J. 1991. Tumor suppressor genes. Cell 64:313–326.
  • Marsilio, E., S. H. Cheng, B. Schaffhausen, E. Paucha, and D. M. Livingston. 1991. The T/t common region of simian virus 40 large T antigen contains a distinct transformation-governing sequence. J. Virol. 65:5647–5652.
  • Michalovitz, D., L. Fischer-Fantuzzi, C. Vesco, J. M. Pipas, and M. Oren. 1987. Activated Ha-ras can cooperate with defective simian virus 40 in the transformation of nonestablished rat embryo fibroblasts. J. Virol. 61:2648–2654.
  • Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoprotein. Science 258:424–429.
  • Peden, K. W., A. Srinivasan, J. M. Farber, and J. M. Pipas. 1989. Mutants with changes within or near a hydrophobic region of simian virus 40 large tumor antigen are defective for binding cellular protein p53. Virology 168:13–21.
  • Pipas, J. M., K. W. C Peden, and D. Nathans. 1983. Mutational analysis of simian virus 40 T antigen: isolation and characterization of mutants with deletions in the T antigen gene. Mol. Cell. Biol. 3:203–213.
  • Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89:4495–4499.
  • Sompayrac, L., and K. J. Danna. 1991. The amino-terminal 147 amino acids of SV40 large T antigen transform secondary rat embryo fibroblasts. Virology 181:412–415.
  • Srinivasan, A., K. W. C Peden, and J. M. Pipas. 1989. The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions. J. Virol. 63:5459–5463.
  • Srinivasan, A., and J. M. Pipas. Unpublished data.
  • Suda, Y., S. Aizawa, Y. Furata, T. Yagi, Y. Ikawa, K. Saitoh, Y. Yamada, K. Toyoshima, and T. Yamamoto. 1990. Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659-Glu659). EMBO J. 9:181–190.
  • Symonds, H., J. Chen, and T. Van Dyke. 1991. Complex formation between the lymphotropic papovavirus large tumor antigen and the tumor suppressor protein p53. J. Virol. 65:5417–5424.
  • Tack, L. C., C. A. Cartwright, J. H. Wright, W. Eckhart, K. W. C Peden, A. Srinivasan, and J. M. Pipas. 1989. Properties of a simian virus 40 mutant T antigen substituted in the hydrophobic region: defective ATPase and oligomerization activities and altered phosphorylation accompany an inability to complex with cellular p53. J. Virol. 63:3362–3367.
  • Tevethia, M. J., J. M. Pipas, T. Kierstead, and C. Cole. 1988. Requirements for immortalization of primary mouse embryo fibroblasts probed with mutants bearing deletions in the 3′ end of SV40 gene A. Virology 162:76–89.
  • Thompson, D. L., D. Kalderon, A. E. Smith, and M. J. Tevethia. 1990. Dissociation of Rb-binding and anchorage-independence growth from immortalization and tumorigenicity using SV40 mutants producing N-terminally truncated large T antigens. Virology 178:15–34.
  • Whyte, P., N. M. Williamson, and E. Harlow. 1989. Cellular targets for transformation by the adenovirus E1A proteins. Cell 56:67–75.
  • Yaciuk, P., M. C. Carter, J. M. Pipas, and E. Moran. 1991. Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products. Mol. Cell Biol. 11:2116–2124.
  • Yan, C., R. H. Costa, J. E. Darnell, Jr., J. Chen, and T. A. Van Dyke. 1990. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J. 9:869–878.
  • Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (London) 352:345.
  • Zhu, J., P. W. Rice, L. Gorsch, M. Abate, and C. N. Cole. 1992. Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen. J. Virol. 66:2780–2791.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.